Skip to content
lifestyle.gopreneurs.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
CorMedix, Inc.
U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation
June 8, 2026
Cormedix Therapeutics to Participate in two Upcoming Investor Conferences
May 24, 2026
Cormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 24, 2026
CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026
May 22, 2026
CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients
May 20, 2026
CorMedix to Participate in Needham Virtual Healthcare Conference
April 7, 2026
CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 5, 2026
CorMedix Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 5, 2026
March 2, 2026
CorMedix to Participate in Upcoming Investor Conferences
February 13, 2026
CorMedix Therapeutics Announces Share Repurchase Program
February 2, 2026
1
2
Next Page
→